Nunaps, a South Korean digital therapeutics startup, has closed a KRW 5 billion (US$ 4.2 million) Series A round by Company K Partners, KTB Network, and K2 Investment Partners. The company plans to use the fresh capital to build digital therapeutics platform related to neurological disorders. Nunaps has recently initiated a pivotal clinical trial of its first product, Nunap … [Read more...] about Nunaps raises US$4.2M to develop patient-centered digital therapeutics platform for brain damage